|
Name |
11-Mercaptoundecanoic acid
|
| Molecular Formula | C11H22O2S | |
| IUPAC Name* |
11-sulfanylundecanoic acid
|
|
| SMILES |
C(CCCCCS)CCCCC(=O)O
|
|
| InChI |
InChI=1S/C11H22O2S/c12-11(13)9-7-5-3-1-2-4-6-8-10-14/h14H,1-10H2,(H,12,13)
|
|
| InChIKey |
GWOLZNVIRIHJHB-UHFFFAOYSA-N
|
|
| Synonyms |
11-Mercaptoundecanoic acid; 71310-21-9; 11-Sulfanylundecanoic acid; Undecanoic acid, 11-mercapto-; 11-mercaptoundecanoicacid; 10-Caroboxy-1-decanethiol; 11-Sulfanylundecanoic acid #; SCHEMBL111144; DTXSID00337585; 11-Mercaptoundecanoic acid, 95%; 11-Mercaptoundecanoic acid, 98%; ZINC2164257; MFCD00022096; STL323763; AKOS015893928; CS-W014785; DB08171; GS-6888; DB-008035; FT-0698883; F11363; A866466; Q27097399
|
|
| CAS | 71310-21-9 | |
| PubChem CID | 543502 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 218.36 | ALogp: | 4.0 |
| HBD: | 2 | HBA: | 3 |
| Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 38.3 | Aromatic Rings: | 0 |
| Heavy Atoms: | 14 | QED Weighted: | 0.425 |
| Caco-2 Permeability: | -5.187 | MDCK Permeability: | 0.00002600 |
| Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.035 | 20% Bioavailability (F20%): | 0.808 |
| 30% Bioavailability (F30%): | 0.95 |
| Blood-Brain-Barrier Penetration (BBB): | 0.006 | Plasma Protein Binding (PPB): | 99.39% |
| Volume Distribution (VD): | 0.435 | Fu: | 2.76% |
| CYP1A2-inhibitor: | 0.066 | CYP1A2-substrate: | 0.2 |
| CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.216 |
| CYP2C9-inhibitor: | 0.077 | CYP2C9-substrate: | 0.972 |
| CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.148 |
| CYP3A4-inhibitor: | 0.006 | CYP3A4-substrate: | 0.029 |
| Clearance (CL): | 6.439 | Half-life (T1/2): | 0.805 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.228 |
| Drug-inuced Liver Injury (DILI): | 0.053 | AMES Toxicity: | 0.074 |
| Rat Oral Acute Toxicity: | 0.102 | Maximum Recommended Daily Dose: | 0.021 |
| Skin Sensitization: | 0.722 | Carcinogencity: | 0.316 |
| Eye Corrosion: | 0.937 | Eye Irritation: | 0.984 |
| Respiratory Toxicity: | 0.869 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000102 | ![]() |
0.773 | D0Z5BC | ![]() |
0.596 | ||
| ENC000270 | ![]() |
0.705 | D0E4WR | ![]() |
0.510 | ||
| ENC000378 | ![]() |
0.680 | D0O1PH | ![]() |
0.479 | ||
| ENC000551 | ![]() |
0.654 | D0XN8C | ![]() |
0.441 | ||
| ENC000916 | ![]() |
0.654 | D07ILQ | ![]() |
0.435 | ||
| ENC000466 | ![]() |
0.642 | D0FD0H | ![]() |
0.432 | ||
| ENC000088 | ![]() |
0.636 | D05ATI | ![]() |
0.410 | ||
| ENC000050 | ![]() |
0.607 | D05QNO | ![]() |
0.381 | ||
| ENC001913 | ![]() |
0.596 | D0Y8DP | ![]() |
0.379 | ||
| ENC000593 | ![]() |
0.596 | D0O1TC | ![]() |
0.378 | ||